A new study from the University of Pittsburgh, USA, shows, for the first time, how exercise improves cancer outcomes and enhances the response to...
Vous n'êtes pas connecté
A new study from the University of Pittsburgh, USA, shows, for the first time, how exercise improves cancer outcomes and enhances the response to immunotherapy in mice by reshaping the gut microbiome. The research, published today in the journal Cell, found that these benefits are driven by a specific compound called formate, which is produced by gut bacteria in exercised mice and was also associated with better outcomes in patients with melanoma. “We already knew that [...]
A new study from the University of Pittsburgh, USA, shows, for the first time, how exercise improves cancer outcomes and enhances the response to...
Pittsburgh: A new study has found that patients with melanoma and non-small cell lung cancer who consumed high levels of sucralose-a widely used...
A comprehensive new review reveals both the promise and challenges of using fecal microbiota transplantation (FMT) to enhance cancer immunotherapy...
A comprehensive new review reveals both the promise and challenges of using fecal microbiota transplantation (FMT) to enhance cancer immunotherapy...
<p> (UrduPoint / Pakistan Point News / WAM - 01st Aug, 2025) PENNSYLVANIA, 1st August, 2025 (WAM) – A new study has found that patients with...
<p> (UrduPoint / Pakistan Point News / WAM - 01st Aug, 2025) PENNSYLVANIA, 1st August, 2025 (WAM) – A new study has found that patients with...
Scientists at the University of Cambridge have identified gut bacteria strains capable of removing harmful PFAS "forever chemicals" from the body. The...
Scientists at the University of Cambridge have identified gut bacteria strains capable of removing harmful PFAS "forever chemicals" from the body. The...
Engineered gut bacteria designed to treat kidney stones successfully colonized the gut microbiome and reduced oxalate levels in animal models and...
Discover how gut and oral bacteria influence immune evasion in esophageal cancer, impacting treatment response and disease progression.